1. Home
  2. CYTK vs ADT Comparison

CYTK vs ADT Comparison

Compare CYTK & ADT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.41

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo ADT Inc.

ADT

ADT Inc.

HOLD

Current Price

$8.27

Market Cap

6.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
ADT
Founded
1997
1874
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
6.6B
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
CYTK
ADT
Price
$62.41
$8.27
Analyst Decision
Strong Buy
Buy
Analyst Count
16
4
Target Price
$82.38
$9.25
AVG Volume (30 Days)
2.2M
4.8M
Earning Date
02-26-2026
02-26-2026
Dividend Yield
N/A
2.67%
EPS Growth
N/A
N/A
EPS
N/A
0.71
Revenue
$87,211,000.00
$5,112,859,000.00
Revenue This Year
$346.43
$6.12
Revenue Next Year
$57.69
$3.60
P/E Ratio
N/A
$11.36
Revenue Growth
2609.26
6.29
52 Week Low
$29.31
$6.79
52 Week High
$70.98
$8.94

Technical Indicators

Market Signals
Indicator
CYTK
ADT
Relative Strength Index (RSI) 49.43 58.82
Support Level $62.05 $7.97
Resistance Level $66.59 $8.23
Average True Range (ATR) 2.97 0.12
MACD 0.09 0.03
Stochastic Oscillator 33.47 79.22

Price Performance

Historical Comparison
CYTK
ADT

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ADT ADT Inc.

ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name. The company segments include Consumer and Small Business (CSB).

Share on Social Networks: